Enhanced oral bioavailability of atorvastatin via oil-in-water nanoemulsion using aqueous titration method

Journal of Pharmaceutical Sciences and Research

Volumn 5, Issue 1, 2013, Pages 18-25

  Jain, Kunal ^a   Suresh Kumar, R ^a   Sood, Sumeet ^a   Gowthamarajan, K ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; First pass metabolism; Lipids; Nanoemulsion; Solubility

Indexed keywords

ALCOHOL; ATORVASTATIN; COSURFACTANT; OLEIC ACID; OZOVAS; POLIDOCANOL; POLYSORBATE 80; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DISSOLUTION; DROPLET SIZE ANALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONTENT; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ELECTRIC CONDUCTIVITY; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NANOEMULSION; NONHUMAN; PERCENT TRANSMITTANCE; PHYSICAL CHEMISTRY; REFRACTION INDEX; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY;

EID: 84873447438     PISSN: 09751459     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chakraborty, S., Shukla, D., Mishra, B., Singh, S., Eur. J. Pharm. Biopharm. 2009, 73, 1-15.
2. Amidon, G.L., Lennernas, H., Shah, V.P., Crison, J.R., Pharm. Res. 1995, 12, 413-20.
3. Lea, A.P., McTavish, D., Drugs. 1997, 53, 828-847.
4. Black, A.E., Hayes, R.N., Roth, B.D., Woo, P., Woolf, T.F., Drug Metab. Dispos. 1999, 27, 916-923.
5. Lennernas, H., Clin. Pharmacokinet. 2003, 42,1141-1160.
6. Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Greco, A., Littarru, G., J. Clin. Pharmacol. 1993,33(3), 226-229.
7. Shafiq, S., Faiyaz, S., Sushma, T., Ahmad, F.J., Khar, R.K., Ali, M., Eur. J. Pharm. Biopharm. 2007, 66, 227-243.
8. Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Aqil, M., Shafiq, S., AAPS. Pharm. Sci. Tech. 2007, 8(4), Article 104.
9. Attwood, D., in: Kreuter, J. (Ed.), Colloidal Drug Delivery Systems, Marcel Dekker, New York, 1994, pp. 31-71.
10. Ghosh, P.K., Majithiya, R.J., Umrethia, M.L., Murthy, R.S.R., AAPS. Pharm. Sci. Tech. 2006, 7(3), Article 77.
11. Freireich, E.J., Gehan, E.A., Rall, D.P., Schmidt, L.H., Skipper, H.E., Cancer. Chemother. Rep. 1966, 50, 219-244.
12. Bali, V., Ali, M., Ali, J., Colloid. Surface. B. 2010, 76, 410-420.
13. Vyas, T.K., Shahiwala, A., Amiji, M.M.,Int.J.Pharm. 2008, 347, 93-101.
14. Pouton, C.W., Eur. J. Pharm. Sci. 2000, 11, S93-S98.
15. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., Masuda, K., J. Control Release. 2002, 81, 75-82.
16. Kommuru, T.R., Gurley, B., Khan, M.A., Reddy, I.K., Int.J.Pharm. 2001, 212, 233-246.
17. Lawrence, M.J., Rees, G.D., Adv. Drug Deliv. Rev. 2000, 45, 89- 121.
18. Hua, L., Weisan, P., Jiayu, L., Ying, Z., Drug Dev. Ind. Pharm. 2004, 30, 657-666.
19. Narang, A.S., Delmarre, D., Gao, D., Int.J.Pharm. 2007, 345, 9-25.
20. Shinoda, K., Kunieda, H., Encyclopedia of Emulsion Technology, Marcel Dekker, New York, 1983, pp. 337-367.
21. Kang, B.K., Lee, J.S., Chon, S.K., Jeong, S.Y., Yuk, S.H., Khang, G., Lee, H.B., Cho, S.H., Int.J.Pharm. 2004, 274, 65-73.
22. Gao, Z.G., Choi, H.G, Shin, H.J.,Park, K.M., Lim, S.J., Kim, C.K.,Int.J.Pharm.1998, 161,75-86.
23. Sintov, A.C., Shapiro, L., J. Control Rel. 2004, 95, 173-83.
24. Zhang, Y.C., Benet, L. Z., Clin Pharmacokinet. 2001,40(3), 159-168.
25. Seeballuck, F., Ashford, M.B., O'Driscoll, C.M., Pharm Res. 2003, 20(7), 1085-1092.
26. Müller, R.H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A.F., Souto, E.B., Int.J.Pharm. 2006, 317, 82-89.